Medicare and GLP-1 Coverage: What To Know

A new, temporary Medicare program called the Medicare GLP-1 Bridge may make certain weight-loss medications more affordable for eligible people with Medicare Part D. Here's a quick look at what's changed, who may qualify, and what to keep in mind.

What’s changed

Starting July 1, 2026, Medicare began the Medicare GLP-1 Bridge, a temporary Centers for Medicare & Medicaid Services demonstration program that runs through December 31, 2027. The program is designed for eligible Medicare Part D beneficiaries using certain GLP-1 drugs for weight loss.

How it works

Eligible beneficiaries pay a flat $50 copay for a monthly supply of covered GLP-1 drugs through the Bridge. The program works outside the usual Medicare Part D coverage and payment flow, so the Part D deductible does not apply.

Who qualifies

To be eligible, beneficiaries generally need to have Medicare Part D coverage, receive prior authorization, and meet certain weight-related criteria. The Bridge is only for weight-loss use.

A few things to know

Covered drugs are limited. The $50 copay does not count toward true out-of-pocket costs, and low-income subsidy assistance does not apply to the Bridge copay. Coupons and discount programs cannot be used for Bridge claims.

Where to learn more

People with Medicare can learn more and check whether they may qualify at 
Medicare.gov/glp1bridge. They can also call 1-800-MEDICARE (1-800-633-4227). TTY users can call 1-877-486-2048.